The Mosaic Company
MOS
$22.30
+0.09%
The Mosaic Company is a leading global producer of phosphate and potash crop nutrients, operating mines and processing facilities in the U.S., Canada, and Brazil, and distributing fertilizers through its Mosaic Fertilizantes business in Brazil. As one of the largest phosphate and potash producers worldwide, Mosaic holds a distinct competitive position due to its low-cost, vertically integrated operations and strategic access to key nutrient reserves. The current investor narrative centers on the potential margin boost from the Strait of Hormuz closure, which has stranded a third of global fertilizer supply and created a massive opportunity for North American producers like Mosaic. However, the stock has faced significant headwinds from declining fertilizer prices and a recent quarterly loss, fueling debate over whether the cyclical downturn is nearing a trough.…
MOS
The Mosaic Company
$22.30
Investment Opinion: Should I buy MOS Today?
Rating: Hold. Mosaic is a cyclical value play with a compelling valuation and a near-term catalyst, but the deteriorating financials and negative momentum warrant caution. The analyst consensus is Buy with an average target of $27.19, implying 22.9% upside, but the wide target range reflects high uncertainty.
Supporting Evidence: The P/S ratio of 0.63x is a 58% discount to the industry average, and the P/B ratio of 0.63x is near historical lows. Revenue grew 14.4% YoY in Q1 2026, but the company posted a net loss of $257.6 million and negative free cash flow of $489.3 million TTM. The EV/EBITDA multiple of 4.84x is low relative to history. The stock offers a 3.67% dividend yield, but the payout ratio of 51.9% may be at risk if cash flow remains negative.
Risks & Conditions: The biggest risks are continued margin compression and cash burn. This Hold would upgrade to Buy if gross margins recover above 15% and free cash flow turns positive, or if the stock falls below $20, offering a deeper value entry. It would downgrade to Sell if revenue growth turns negative or the company cuts its dividend. Overall, Mosaic appears undervalued relative to its asset base and historical multiples, but the near-term earnings trajectory is too weak to justify a Buy rating.
Sign up to view all
MOS 12-Month Price Forecast
Mosaic is a deeply cyclical stock trading at a significant discount to its asset value and historical multiples. The near-term financials are weak, with negative earnings and cash flow, but the valuation provides a margin of safety. The Hormuz closure is a wild card that could drive a sharp recovery if sustained. The neutral stance reflects the balance between deep value and deteriorating fundamentals. An upgrade to bullish would require evidence of margin stabilization and positive free cash flow, while a downgrade to bearish would follow further price declines or a dividend cut.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on The Mosaic Company's 12-month outlook, with a consensus price target around $27.19 and implied upside of +21.9% versus the current price.
Average Target
$27.19
0 analysts
Implied Upside
+21.9%
vs. current price
Analyst Count
—
covering this stock
Price Range
$19 - $35
Analyst target range
Mosaic is covered by 19 analysts, with a consensus recommendation of 'Buy' (mean rating 2.25 on a 1-5 scale where 1 is Strong Buy). The average target price is $27.19, implying approximately 22.9% upside from the current price of $22.13. The distribution leans bullish: 10 analysts rate it Buy or Outperform, 7 at Hold/Neutral, and 2 at Underweight/Sell. Recent ratings actions include upgrades from RBC Capital (Sector Perform to Outperform) and Freedom Broker (Sell to Buy), while JP Morgan remains Underweight. The target range spans from a low of $19.00 to a high of $35.00. The low target suggests a scenario where fertilizer prices remain depressed and the company continues to burn cash, potentially leading to further downside. The high target of $35.00 implies a 58% upside, likely assuming a recovery in phosphate and potash prices, successful cost-cutting, and the benefit from the Hormuz closure. The wide spread between low and high ($16.00) indicates high uncertainty about the timing and magnitude of a cyclical recovery. The consensus EPS estimate for the current fiscal year is $2.23, which would imply a forward P/E of 9.9x, but this estimate may be overly optimistic given the recent loss. Overall, the analyst community sees value but acknowledges significant near-term risks.
Drowning in data?
Find the real signal!
Bulls vs Bears: MOS Investment Factors
Mosaic presents a classic cyclical value opportunity with a deep valuation discount (P/S 0.63x, P/B 0.63x) and a potential catalyst from the Strait of Hormuz closure. However, the company is currently unprofitable, burning cash, and in a sustained downtrend. The bull case hinges on a cyclical recovery in fertilizer prices and the Hormuz catalyst boosting margins, while the bear case centers on continued price weakness and cash burn. The single most important tension is whether fertilizer prices have reached a trough and will rebound, or if the downturn will persist, further eroding Mosaic's financial position. Currently, the bearish evidence from recent financials is stronger, but the valuation and catalyst provide a compelling risk/reward for patient investors.
Bullish
- Strait of Hormuz Closure Catalyst: The closure of the Strait of Hormuz has stranded a third of global fertilizer supply, creating a massive margin opportunity for North American producers like Mosaic. This geopolitical event could significantly boost Mosaic's phosphate and potash pricing and volumes in the coming quarters.
- Deep Value Valuation: Mosaic trades at a P/S ratio of 0.63x, a 58% discount to the agricultural inputs industry average of ~1.5x. The P/B ratio of 0.63x is near historical lows, suggesting the stock is priced below book value and offers a margin of safety if the cycle turns.
- Analyst Consensus Bullish: 19 analysts rate Mosaic a consensus 'Buy' with a mean rating of 2.25 (1=Strong Buy). The average target price of $27.19 implies 22.9% upside from the current price of $22.13, with a high target of $35.00 representing 58% upside.
- Revenue Growth in Q1 2026: Revenue in Q1 2026 was $2.998 billion, up 14.4% year-over-year, driven by the Mosaic Fertilizantes segment and higher volumes. This growth demonstrates the company's ability to increase sales despite challenging fertilizer price conditions.
Bearish
- Negative Net Income and Margins: Mosaic reported a net loss of $257.6 million in Q1 2026, with gross margin collapsing to 7.9% from 14.2% in Q4 2025 and operating margin turning negative at -12.4%. The company is unprofitable on a TTM basis, with a net margin of -8.6%.
- Negative Free Cash Flow: Free cash flow was -$252.6 million in Q1 2026 and -$489.3 million on a TTM basis, driven by high capital expenditures of $356.8 million. This cash burn raises concerns about the company's ability to fund operations and dividends without increasing debt.
- Sustained Price Downtrend: The stock has declined 37.3% over the past year, significantly underperforming the S&P 500's 18.4% gain. The current price of $22.13 is near the 52-week low of $19.80, indicating persistent selling pressure and negative momentum.
- Cyclical Downturn in Fertilizer Prices: Fertilizer prices have been declining from post-pandemic peaks, compressing margins across the industry. Mosaic's Q1 2026 results reflect this, with revenue growth driven by volumes rather than pricing, and profitability deteriorating sharply.
MOS Technical Analysis
Mosaic is in a sustained downtrend, with the stock price declining 37.3% over the past year, significantly underperforming the S&P 500's 18.4% gain. The current price of $22.13 sits at 59% of its 52-week range (low $19.80, high $37.53), indicating the stock is closer to its lows than highs. This positioning suggests the market is pricing in continued weakness, but also raises the possibility of a value opportunity if fundamentals stabilize. Short-term momentum shows a mixed picture: the 1-month change is -1.7%, while the 3-month change is -9.9%, indicating ongoing selling pressure. However, the 1-month decline is less severe than the 3-month drop, hinting at a potential deceleration in the downtrend. The stock's beta of 0.825 implies it is less volatile than the market, meaning it may not participate as strongly in broad market rallies but also offers relative downside protection. The 52-week low of $19.80 provides a key support level; a break below could signal further downside toward the next support zone. Conversely, the 52-week high of $37.53 represents major resistance; a breakout above that level would require a fundamental catalyst and could indicate a trend reversal. The stock's relative strength versus the S&P 500 is deeply negative across all time frames, confirming persistent underperformance.
Beta
0.82
0.82x market volatility
Max Drawdown
-47.6%
Largest decline past year
52-Week Range
$20-$37
Price range past year
Annual Return
-40.4%
Cumulative gain past year
| Period | MOS Return | S&P 500 |
|---|---|---|
| 1m | +6.9% | +0.8% |
| 3m | -7.1% | +3.5% |
| 6m | -22.5% | +7.2% |
| 1y | -40.4% | +16.5% |
| ytd | -10.9% | +8.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MOS Fundamental Analysis
Revenue in the most recent quarter (Q1 2026) was $2.998 billion, up 14.4% year-over-year, but this growth was driven by the Mosaic Fertilizantes segment and higher volumes rather than pricing power. However, the trajectory is uneven: revenue has fluctuated between $2.6 billion and $3.45 billion over the past four quarters, with the Q1 2026 figure below the Q3 2025 peak of $3.452 billion. The Phosphates segment contributed $1.426 billion, Potash $671 million, and Mosaic Fertilizantes $937 million, showing diversification but also reliance on the Brazilian distribution business. The growth rate is decelerating from the 31.5% YoY growth seen in Q2 2025, suggesting that the post-pandemic fertilizer boom has faded. Profitability has deteriorated sharply: net income in Q1 2026 was -$257.6 million, compared to positive net income of $162.2 million in Q4 2025 and $411.4 million in Q3 2025. Gross margin collapsed to 7.9% in Q1 2026 from 14.2% in Q4 2025 and 16.0% in Q3 2025, reflecting lower phosphate and potash prices and higher input costs. The operating margin turned negative at -12.4%, a stark reversal from the 9.0% operating margin in Q4 2025. The company is unprofitable on a trailing twelve-month basis, with a net margin of -8.6% in Q1 2026, though the full-year 2025 net margin was 6.2%. The balance sheet shows moderate leverage: debt-to-equity of 0.44 and a current ratio of 1.32, indicating adequate liquidity. However, free cash flow was -$252.6 million in Q1 2026 and -$489.3 million on a TTM basis, driven by high capital expenditures of $356.8 million. ROE was 4.5% on a trailing basis, but the negative net income in Q1 2026 has eroded returns. The company's ability to fund operations internally is strained, and it may need to rely on debt or asset sales if the downturn persists.
Quarterly Revenue
$3.0B
2026-03
Revenue YoY Growth
+14.4%
YoY Comparison
Gross Margin
7.9%
Latest Quarter
Free Cash Flow
$-489300000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MOS Overvalued?
Since net income is negative on a trailing twelve-month basis (TTM net income of -$257.6 million in Q1 2026), the P/E ratio is not meaningful. Therefore, we use the price-to-sales (P/S) ratio as the primary valuation metric. The trailing P/S ratio is 0.63x, while the forward P/S (based on estimated revenue of $11.6 billion) is approximately 0.66x, suggesting the market expects a slight revenue decline. The gap between trailing and forward P/S is minimal, indicating stable sales expectations. Compared to the agricultural inputs industry average P/S of roughly 1.5x (estimated), Mosaic's 0.63x represents a 58% discount. This discount is likely justified by the company's negative earnings and weak margins, but it also reflects the cyclical trough. Historically, Mosaic's P/S ratio has ranged from 0.5x to 6.2x over the past five years, with the current level near the bottom of that range. The P/B ratio of 0.63x is also near historical lows, suggesting the stock is trading below book value. This implies the market is pricing in further asset impairments or a prolonged downturn, but it could also signal a deep value opportunity if the cycle turns. The EV/EBITDA multiple of 4.84x is low relative to historical averages of 10-15x, further supporting the notion that the stock is cheap on an enterprise value basis.
PE
14.2x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 4x~12x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
4.8x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Mosaic's financial health is under pressure, with a net loss of $257.6 million in Q1 2026 and negative free cash flow of $489.3 million TTM. The debt-to-equity ratio of 0.44 is manageable, but the current ratio of 1.32 suggests limited liquidity. The company's reliance on high capital expenditures ($356.8 million in Q1 2026) to maintain operations strains cash flow, and if the downturn persists, Mosaic may need to cut dividends (current yield 3.67%) or increase leverage. Revenue concentration in phosphate and potash exposes the company to commodity price volatility, as seen in the gross margin collapse from 16.0% in Q3 2025 to 7.9% in Q1 2026.
Market & Competitive Risks: Mosaic trades at a significant discount to the industry average P/S of 1.5x, but this discount may be justified by its negative earnings. The stock's beta of 0.825 indicates lower market correlation, but it has underperformed the S&P 500 by 55.6% over the past year, suggesting sector-specific headwinds. Competitive risks include global oversupply of fertilizers and the potential for the Hormuz closure to be resolved quickly, removing the catalyst. Regulatory risks include environmental regulations on mining and fertilizer production, which could increase costs.
Worst-Case Scenario: If fertilizer prices continue to decline and the Hormuz closure is resolved without lasting impact, Mosaic could face further margin compression and cash burn. The realistic downside is to the 52-week low of $19.80, representing a -10.5% decline from the current price of $22.13. However, if the company reports another quarterly loss and cuts its dividend, the stock could fall to the analyst low target of $19.00, a -14.1% decline. In a severe recession scenario, historical max drawdown of -47.6% suggests a potential decline to $11.60, though this is less likely given the current valuation floor.
FAQ
The primary risk is continued margin compression, as seen in Q1 2026 with gross margin falling to 7.9% and a net loss of $257.6 million. Second, negative free cash flow of $489.3 million TTM raises concerns about dividend sustainability (payout ratio 51.9%) and the need for additional debt. Third, the stock is in a sustained downtrend, down 37.3% over the past year, and could fall further if fertilizer prices decline. Fourth, the Hormuz closure catalyst may prove temporary if resolved quickly, removing a key bullish driver. Finally, the company's high capital expenditure requirements ($356.8 million in Q1 2026) strain cash flow and limit financial flexibility.
The 12-month outlook is mixed, with three scenarios: a bull case (25% probability) where the Hormuz closure persists and fertilizer prices surge, driving the stock to $28-$35; a base case (50% probability) of gradual margin improvement and price stabilization, leading to a target of $22-$27; and a bear case (25% probability) of continued price declines and cash burn, pushing the stock to $19-$22. The base case aligns with the analyst average target of $27.19, implying 22.9% upside. The most likely scenario is a slow recovery, with the stock trading in the low-to-mid $20s over the next year. Key assumptions include stable fertilizer prices and successful cost-cutting.
Mosaic is a high-risk, high-reward investment suitable for contrarian investors with a long-term horizon. The stock trades at a deep discount (P/S 0.63x, P/B 0.63x) and offers a 3.67% dividend yield, but the company is currently unprofitable with negative free cash flow. The analyst consensus is Buy with an average target of $27.19, implying 22.9% upside, but the wide target range ($19-$35) reflects high uncertainty. The biggest downside risk is continued margin compression, which could push the stock to $19. For investors willing to bet on a cyclical recovery and the Hormuz catalyst, the risk/reward is attractive at current levels. However, conservative investors should wait for evidence of margin stabilization before buying.
Mosaic is better suited for long-term, patient investors with a 12-24 month horizon, given its cyclical nature and current trough in earnings. The stock's beta of 0.825 indicates lower volatility than the market, but its 37.3% decline over the past year shows it can be highly volatile in downturns. The 3.67% dividend yield provides some income, but the payout may be at risk if cash flow remains negative. Short-term trading is risky due to negative momentum and high uncertainty around fertilizer prices. A minimum holding period of 12 months is recommended to allow for a potential cyclical recovery. The stock is not suitable for income-focused investors seeking stable dividends or for those with low risk tolerance.
